A good beginning in the perilous biotech business Interviewee/Contributor Ingmar Hoerr Organisation CureVac GmbH Vaccine Cancer (Oncology) Prostate cancer mRNA - Messenger Ribonucleir Acid Read more about A good beginning in the perilous biotech business